Nottingham-based Contract Research Organisation (CRO) Cellomatics Biosciences has announced the appointment of Professor David Lambert, FRCA and FFPMRCA as Chief Scientific Officer (CSO).
Based in Nottingham, Cellomatics is a specialist preclinical CRO with expertise in five main therapeutic areas: oncology, immuno-oncology, immunology, inflammation and respiratory. Founded in 2015, Cellomatics has since positioned itself as the CRO of choice for its growing global client base seeking expert support with the development of bespoke bioassays.